UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...

UiPath Inc PATH shares have traded lower in 2026, despite a strong earnings report in December. Shares could be volatile this week with the company reporting fourth-quarter financial results Wednesday ...

UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...

UiPath stock fell in premarket trading despite beating Q4 earnings estimates, as investors reacted cautiously to the ...

If you are wondering whether UiPath's current share price really reflects what the business is worth, you are not alone. This article will help you unpack that question. UiPath shares last closed at ...

UiPath, Inc.’s PATH shares have lost 49.8% in the year-to-date period. This drop is in stark contrast to 29.7% growth of the industry and 21.5% increase of the Zacks S&P 500 composite. PATH’s shares ...

UiPath Inc. beat expectations on earnings and revenue in its latest financial results, doubled its profitability and offered ...

What UiPath’s recent performance tells investors Without a specific news catalyst driving headlines today, UiPath (PATH) is drawing attention for its recent share performance and fundamentals, which ...

UiPath beat revenue and profit estimates but guided cautiously on macroeconomic uncertainty. Retail traders, however, are ...

UiPath (NYSE:PATH) introduced new AI tools for healthcare at the ViVE 2026 conference. The offerings include medical records summarization, claim denial prevention, and prior authorization support.